Author

G. Xi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Mania-Farnell· 1 shared C. D. James· 1 shared C. Jie· 1 shared C. S. Nelson· 1 shared C. Wang· 1 shared D. Kang· 1 shared E. Cisneros de la Rosa· 1 shared F. Fu· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Mania-Farnell

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

WDR82 mediated H3K4me3 is associated with tumor proliferation and therapeutic efficacy in pediatric high-grade gliomas

N. Wadhwani, S. Nayak, Y. Wang, R. Hashizume, C. Jie, B. Mania-Farnell, C. D. James, G. Xi, T. Tomita

The paper shows that WDR82-mediated H3K4me3 promotes tumor proliferation and affects therapeutic response in pediatric high-grade gliomas.

bioRxiv · Mar 9, 2022Cancer Biology

Wound-like tumor periphery in human breast cancer predicts a convergent drug nonresponse

L. Li, X. Liao, F. Fu, G. Xi, D. Kang, J. He, W. Guo, L. Qiu, Z. Han, X. Wang, Q. Zhan, S. You, J. Chen, C. Wang, S. A. Boppart, H. Tu

The paper identifies a wound-like tumor periphery in breast cancer as a uniparameter marker predicting multidrug nonresponse and poor prognosis across molecular subtypes.

bioRxiv · Nov 2, 2021 · PreprintPathology

HCMV glycoprotein B subunit vaccine efficacy was mediated by non-neutralizing antibody effector functions

C. S. Nelson, T. Huffman, E. Cisneros de la Rosa, G. Xi, N. Vandergrift, R. F. Pass, J. Pollara, S. R. Permar

This paper shows that the HCMV gB/MF59 vaccine's 50% efficacy is due to non-neutralizing antibodies that mediate virion phagocytosis, not neutralization.

bioRxiv · Jan 11, 2018Immunology